3.4. Triple Combination Therapy Controls Orthotopic Tumour Growth and Attenuates Metastasis in Pancreatic Cancer Within an Immunocompetent Model When Extending IL-2 Supplementation. The gene discussed is IL2; the disease is pancreatic neoplasm.